- Home
- HIHO vs HOTH Comparison
HIHO vs HOTH Comparison
Compare HIHO & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- HOTH
- Stock Information
- Founded
- HIHO 1990
- HOTH 2017
- Country
- HIHO Hong Kong
- HOTH United States
- Employees
- HIHO N/A
- HOTH N/A
- Industry
- HIHO Industrial Machinery/Components
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- HOTH Health Care
- Exchange
- HIHO Nasdaq
- HOTH Nasdaq
- Market Cap
- HIHO 8.2M
- HOTH 8.3M
- IPO Year
- HIHO 1996
- HOTH 2019
- Fundamental
- Price
- HIHO $1.82
- HOTH $0.98
- Analyst Decision
- HIHO
- HOTH Strong Buy
- Analyst Count
- HIHO 0
- HOTH 4
- Target Price
- HIHO N/A
- HOTH $4.75
- AVG Volume (30 Days)
- HIHO 1.7K
- HOTH 538.3K
- Earning Date
- HIHO 01-21-2025
- HOTH 05-13-2025
- Dividend Yield
- HIHO 6.52%
- HOTH N/A
- EPS Growth
- HIHO N/A
- HOTH N/A
- EPS
- HIHO N/A
- HOTH N/A
- Revenue
- HIHO $7,345,000.00
- HOTH N/A
- Revenue This Year
- HIHO N/A
- HOTH N/A
- Revenue Next Year
- HIHO N/A
- HOTH N/A
- P/E Ratio
- HIHO N/A
- HOTH N/A
- Revenue Growth
- HIHO 11.36
- HOTH N/A
- 52 Week Low
- HIHO $1.70
- HOTH $0.58
- 52 Week High
- HIHO $2.88
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- HIHO 43.61
- HOTH 42.50
- Support Level
- HIHO $1.83
- HOTH $1.01
- Resistance Level
- HIHO $1.91
- HOTH $1.19
- Average True Range (ATR)
- HIHO 0.04
- HOTH 0.07
- MACD
- HIHO -0.00
- HOTH -0.01
- Stochastic Oscillator
- HIHO 18.18
- HOTH 1.76
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.